Consequence of COVID-19 on allergic asthma outcomes: a systematic review and meta-analysis.
Allergol Immunopathol (Madr)
; 52(4): 73-80, 2024.
Article
em En
| MEDLINE
| ID: mdl-38970268
ABSTRACT
Asthma is a common chronic lung disease, and COVID-19 pandemic as a respiratory viral disease led to lung infection and resulted in millions of deaths. So, the impact of COVID-19 on asthma outcomes and the risk of being infected or hospitalized should be clarified. Systematic review and meta-analysis on the outcomes and risk of asthma for people with COVID-19 was done by searching electronic databases between 1 December 2019 and 31 July 2023. A total of 48 studies from 27 countries spread across all continents were included in the review. The prevalence of asthma among COVID-19 patients was 7.9%, and the analysis demonstrated a 16.5% reduction in the risk ratio for acquiring COVID-19 among subjects with asthma compared to those without asthma. There was no statistically significant difference in hospitalization risk, ICU admission risk, and death risk for COVID-19 patients with no asthma compared to those with asthma. The risk of death from COVID-19 was similar between nonasthmatics and asthmatics. The findings indicated that subjects with asthma may be at a lower risk of having infection with COVID-19 compared to those without asthma, but they have a similar risk of hospitalization and mortality.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Asma
/
COVID-19
/
Hospitalização
Limite:
Humans
Idioma:
En
Revista:
Allergol Immunopathol (Madr)
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
China
País de publicação:
Singapura